The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia

MASON, K. D ; KHAW, S. L ; ROBERTS, A. W ; RAYEROUX, K. C ; CHEW, E ; LEE, E. F ; FAIRLIE, W. D ; GRIGG, A. P ; SEYMOUR, J. F ; SZER, J ; HUANG, Dcs

Leukemia, 2009-11, Vol.23 (11), p.2034-2041 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível